Global mobility trends in the biotech industry
The biotech sector continues to be one of the most internationally connected industries in the world
Biotech companies are continuing to expand their global footprints to access talent, investment opportunities and new markets.
The biotech sector continues to be one of the most internationally connected industries in the world. Rapid scientific innovation, increasing investment in emerging technologies and the globalisation of research and development activities have created a growing need for companies to deploy specialist talent across borders.
As organisations compete for expertise in areas such as cell and gene therapy, artificial intelligence, precision medicine and advanced manufacturing, global mobility is increasingly being viewed as a strategic enabler of growth rather than simply an administrative or compliance function.
The global competition for specialist talent
Access to skilled talent remains one of the most significant challenges facing biotech organisations. Many companies are expanding recruitment efforts internationally to address shortages of experienced professionals in research, clinical development, regulatory affairs and bioinformatics.
The increasing use of artificial intelligence throughout the drug development lifecycle is creating additional demand for highly specialised employees with expertise spanning both life sciences and technology. As a result, organisations are adopting more flexible approaches to international hiring, including global recruitment, remote working arrangements and cross-border assignments.
Competition for talent is further intensified by the global nature of biotech innovation. Organisations are increasingly required to move scientists, engineers and technical specialists across multiple jurisdictions to support research programmes, technology transfers and commercialisation activities, often at short notice.
A shift towards more flexible mobility models
Whilst traditional long-term expatriate assignments continue to play an important role, biotech organisations are increasingly utilising shorter-term and more agile forms of mobility.
Employees are often deployed internationally to support clinical trials, oversee technology transfers, assist with manufacturing projects, manage regulatory inspections or participate in collaborative research initiatives. These business needs frequently require mobility solutions that can be implemented quickly and adapted as projects evolve.
As a result, global mobility teams are managing a broader mix of employee arrangements, including short-term assignments, project-based deployments, international remote working arrangements and frequent business travel. This trend is particularly evident within research and development functions, where expertise may need to be deployed across multiple locations during different stages of product development.
International expansion continues to drive cross-border movement
Biotech companies are continuing to expand their global footprints to access talent, investment opportunities and new markets. Established hubs such as the US, UK and Switzerland continue to attract significant investment, while emerging life sciences centres across APAC and Europe are becoming increasingly important.
This internationalisation of operations has increased the need for cross-border collaboration between research teams, manufacturing facilities and commercial functions. Consequently, organisations are increasingly relying on global mobility programmes to facilitate the movement of key personnel and ensure business continuity across jurisdictions.
Funding cycles are also influencing mobility patterns. Following successful investment rounds, organisations often need to scale quickly by deploying key personnel internationally to establish new operations, support production capabilities or accelerate research initiatives. Conversely, periods of funding constraint may lead organisations to reassess assignment structures and place greater emphasis on cost-effective mobility solutions and local talent deployment.
Increasing focus on compliance and risk management
As employee movement becomes more fluid and less predictable, organisations face a growing range of compliance challenges.
Cross-border working arrangements can trigger employment tax, payroll, social security, immigration and corporate tax obligations in multiple jurisdictions. Business travellers and remote workers may create compliance risks that are difficult to identify without robust governance processes and effective employee tracking mechanisms.
An emerging area of focus for many biotech organisations is the potential corporate tax impact of globally dispersed research and development teams. Scientists and researchers working across borders may create permanent establishment risks in certain jurisdictions, particularly where they undertake key decision-making activities, manage significant projects or contribute to commercially valuable research functions.
Organisations are also facing increasing complexity in managing payroll withholding and social security obligations for internationally mobile scientists and specialist researchers who regularly work across multiple countries. Determining the correct social security position and ensuring payroll compliance can be particularly challenging where employees undertake a combination of business travel, short-term assignments and hybrid working arrangements across several jurisdictions.
In response, many organisations are investing in enhanced mobility governance frameworks, traveller tracking solutions and technology-driven compliance monitoring tools to improve visibility over employee movements and manage potential exposures more effectively.
Technology is transforming global mobility
Technology is becoming an increasingly important component of successful mobility programmes.
Advanced mobility platforms are helping organisations automate administrative processes, improve compliance monitoring and provide a more seamless employee experience. Data analytics is also enabling mobility teams to make more informed decisions regarding costs, policy design and workforce planning.
At the same time, the broader adoption of artificial intelligence across the biotech sector is creating expectations that HR and mobility functions will modernise their own operating models and leverage technology to improve efficiency and scalability.
Technology is also helping organisations address increasingly complex compliance requirements by improving visibility over employee location data, business travel activity and cross-border working patterns. This is becoming critical as mobility programmes seek to manage employment tax, social security and permanent establishment risks in a more proactive manner.
As mobility programmes expand to encompass business travellers, assignees and remote workers, organisations are increasingly seeking integrated solutions that bring these populations together in a single platform. BR Navigator combines assignment management, business travel and remote working oversight in one connected environment, helping employers streamline workflows, improve decision-making and maintain a consistent view of their globally mobile workforce.
Looking ahead
Global mobility in the biotech sector is undergoing a period of rapid transformation. Talent shortages, international expansion, technological innovation and increasing compliance demands are reshaping how organisations deploy and support globally mobile employees.
At the same time, emerging issues such as permanent establishment risk arising from cross-border R&D activities, increasingly complex social security and payroll obligations for internationally mobile scientists, and the influence of funding cycles on workforce deployment strategies are adding new layers of complexity to global mobility initiatives.
As the industry continues to evolve, mobility planning will need to become increasingly strategic, technology-enabled and employee-focused. Those organisations that can successfully combine flexibility with strong governance will be best placed to support innovation, manage risk and compete for talent in an increasingly global marketplace.
How Blick Rothenberg can help
As biotech organisations continue to expand internationally and adopt more flexible workforce models, having the right combination of advisory expertise and technology is becoming increasingly important.
Our Global Mobility specialists help organisations navigate the tax, payroll, social security, immigration and compliance challenges associated with international employee movement. Through BR Navigator, our integrated global mobility platform, we can also provide greater visibility over assignments, business travel and remote working arrangements, helping employers manage risk and make informed decisions with confidence.
To discuss how your organisation can build a more effective, technology-enabled global mobility programme, contact our team or Alan using the form below.
Contact Alan Tam
You may also be interested in
Renewable Energy Sector – Top 10 considerations for your 2026 operational and strategic review
Autumn Budget 2026: What Could Tax Changes Mean for Employee Share Schemes?